Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07131644) titled 'Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: West China Hospital
Condition:
Kaposiform Hemangioendothelioma
Intervention:
Drug: Sirolimus
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: August 13, 2025
Target Sample Size: 120
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07131644
Published by HT Digital C...